JP2010513259A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513259A5
JP2010513259A5 JP2009540868A JP2009540868A JP2010513259A5 JP 2010513259 A5 JP2010513259 A5 JP 2010513259A5 JP 2009540868 A JP2009540868 A JP 2009540868A JP 2009540868 A JP2009540868 A JP 2009540868A JP 2010513259 A5 JP2010513259 A5 JP 2010513259A5
Authority
JP
Japan
Prior art keywords
carbohydrate
fat
nutritional
composition
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009540868A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513259A (ja
Filing date
Publication date
Priority claimed from GBGB0624879.3A external-priority patent/GB0624879D0/en
Application filed filed Critical
Publication of JP2010513259A publication Critical patent/JP2010513259A/ja
Publication of JP2010513259A5 publication Critical patent/JP2010513259A5/ja
Pending legal-status Critical Current

Links

JP2009540868A 2006-12-14 2007-12-14 広汎性発達障害の治療 Pending JP2010513259A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0624879.3A GB0624879D0 (en) 2006-12-14 2006-12-14 Treatment of pervasive development disorders
PCT/GB2007/004815 WO2008071991A1 (en) 2006-12-14 2007-12-14 Treatment of pervasive developmental disorders

Publications (2)

Publication Number Publication Date
JP2010513259A JP2010513259A (ja) 2010-04-30
JP2010513259A5 true JP2010513259A5 (cg-RX-API-DMAC7.html) 2012-03-22

Family

ID=37712065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540868A Pending JP2010513259A (ja) 2006-12-14 2007-12-14 広汎性発達障害の治療

Country Status (16)

Country Link
US (1) US20100055073A1 (cg-RX-API-DMAC7.html)
EP (1) EP2091526B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010513259A (cg-RX-API-DMAC7.html)
AT (1) ATE507827T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007331276A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0720230B8 (cg-RX-API-DMAC7.html)
CA (1) CA2672738A1 (cg-RX-API-DMAC7.html)
DE (1) DE602007014400D1 (cg-RX-API-DMAC7.html)
ES (1) ES2365469T3 (cg-RX-API-DMAC7.html)
GB (1) GB0624879D0 (cg-RX-API-DMAC7.html)
IL (1) IL199340A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009006459A (cg-RX-API-DMAC7.html)
PL (1) PL2091526T3 (cg-RX-API-DMAC7.html)
RU (1) RU2441652C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008071991A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200904240B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010137944A1 (en) * 2009-05-27 2010-12-02 N.V. Nutricia Treatment of hypercalcaemia
MX2013003636A (es) 2013-03-27 2014-09-29 Palsgaard Ind De Mexico S De R L De C V Complemento alimenticio para personas con trisomia 21, transtorno del espectro autista y/o transtorno por deficit de atencion con o sin hiperactividad.
WO2015002527A1 (en) * 2013-07-05 2015-01-08 N.V. Nutricia Amino acid composition for use in the treatment of a pdd
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2018201024A1 (en) 2017-04-28 2018-11-01 Axcella Health Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
US11541068B2 (en) 2017-05-24 2023-01-03 Glycom A/S HMO compositions and methods for reducing autism spectrum disorder symptoms
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
WO2022258873A1 (es) * 2021-06-09 2022-12-15 Hospital Sant Joan De Deu Combinación nutracéutica y su uso para el tratamiento de trastornos neurológicos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
US20020155170A1 (en) * 2000-11-30 2002-10-24 Walsh William John Nutrient supplements and methods for treating autism and for preventing the onset of autism
CN1255413C (zh) * 2001-06-14 2006-05-10 阿克佐诺贝尔公司 作为ampa受体正性调节剂的(吡啶并/噻吩并)-[f]-氧杂吖庚因-5-酮衍生物
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions

Similar Documents

Publication Publication Date Title
ES2555257T3 (es) Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales
RU2009126763A (ru) Лечение общих расстройств развития
ES2436145T3 (es) Método para disminuir el amargor y mejorar el sabor de leches maternizadas sin proteínas e hidrolizadas
JP2005501061A5 (cg-RX-API-DMAC7.html)
JP2009534323A5 (cg-RX-API-DMAC7.html)
ES2111384T3 (es) Composicion dietetica para adolescentes.
WO2008081582A1 (ja) 容器詰飲料
CA2177195A1 (en) Method and composition for treating renal failure
RU2013151083A (ru) ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ α-ГИДРОКСИИЗОКАПРОНОВУЮ КИСЛОТУ (α-HICA) И ЦИТРУЛЛИН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2016509994A5 (cg-RX-API-DMAC7.html)
JP2023507064A (ja) タンパク質に由来するアミノ酸の生物学的利用能の上昇に使用するための菌株を含む組成物
JP5687697B2 (ja) 体重増加の抑制及び/又は体重減少に使用するための魚類タンパク質の加水分解産物
RU2015133023A (ru) Активация адипонектина с использованием гидролизата казеина
US20210127647A1 (en) Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease
KR900013872A (ko) 영양 조성물
WO2018050708A1 (en) Spoonable nutritional composition
WO2013004865A8 (es) Suplemento alimenticio, método para incrementar la masa bacteriana en el rumen de un rumiante y preparado alimenticio y usos correspondientes
JPH04159219A (ja) 腎不全用経口アミノ酸製剤
JP2005289938A5 (cg-RX-API-DMAC7.html)
Chung et al. Effects of Proteolytic Activity of Multi-Species Probiotics on Dietary Protein Absorption and Muscle Physiology
JP2025515787A5 (cg-RX-API-DMAC7.html)
Franzói De Moraes et al. Creatine supplementation in trained rats causes changes in myenteric neurons and intestinal wall morphometry
JP6423717B2 (ja) 非糖質性エネルギー産生増強剤
ES2132021A1 (es) Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
INC GLUCA-BALANCE